A Two-Pronged Approach to Automation for Gene Therapy Research
The field of cell and gene therapy is exploding, thanks in large part to the Nobel Prize-winning gene editing technology, the CRISPR-Cas9 system. Beam Therapeutics, a biotech company developing a new class of genetic medicines, uses similar technology, but using a more precise, higher efficiency approach. To achieve their goal of treating genetic diseases caused by point mutations, Beam scientists needed a fully automated data pipeline to support complex and demanding research.
In this white paper, we cover:
The challenges associated with high-throughput gene therapy discovery
How robotics and data automation work hand in hand to with Benchling
The impact of Benchling on faster, more reliable discovery